TY - JOUR
T1 - Antigens specific for human T-lymphocytes detected by xenoantisera to HD-MAR cells
T2 - Their differential expression on various T-cell lines
AU - Rabinowitz, R.
AU - Weinstock, J.
AU - Margalioth, E. J.
AU - Ben-Bassat, H.
AU - Schlesinger, M.
PY - 1982/6
Y1 - 1982/6
N2 - Sera elicited in rabbits by immunization with a newly established T-cell line. HD-MAR, and absorbed with human B-cell lines, were found to posses distinct properties. Although they killed the majority of human thymus cells, they killed no more than 20% of peripheral blood lymphocytes (PBL). HD-MAR antisera failed to react with B lymphocytes and with the Molt-4 and Peer T-cell lines, but exerted a strong cytotoxic effect on the HD-MAR, Be-13, HPB-ALL, and Amsalem T-cell lines. Following absorption with Amsalem cells, HD-MAR antiserum failed to react with Amsalem cells, yet reacted strongly with thymus cells and HD-MAR cells. The sensitivity of the various cell lines to the cytotoxic activity of HD-MAR antiserum absorbed with Amsalem cells showed a striking correlation with their capacity to form E-rosettes. Trypsin treatment of Amsalem cells eliminated their sensitivity to the cytotoxic effect of HD-MAR antisera. In contrast, trypsin-treated thymus and HD-MAR cells maintained their sensitivity to HD-MAR antiserum. Absorption of HD-MAR antiserum with trypsinized thymus cells did not affect the activity of the antiserum on untreated thymus, HD-MAR, and Amsalem cells, but eliminated its activity on trypsinized cells. Thus, all T-cell types tested seem to share a trypsin sensitive antigen. Amsalem cells, however, lack a trypsin resistant antigen present in other T-cell lines. A third antigenic determinant detected by HD-MAR antiserum seemed to be associated with the E-receptor. Preliminary observations indicate that HD-MAR antiserum is strongly cytotoxic for activated T-lymphocytes. The relationship of the antigenic specificities detected by the antiserum and the antigenic changes occurring in the membrane of activated T cells is under investigation.
AB - Sera elicited in rabbits by immunization with a newly established T-cell line. HD-MAR, and absorbed with human B-cell lines, were found to posses distinct properties. Although they killed the majority of human thymus cells, they killed no more than 20% of peripheral blood lymphocytes (PBL). HD-MAR antisera failed to react with B lymphocytes and with the Molt-4 and Peer T-cell lines, but exerted a strong cytotoxic effect on the HD-MAR, Be-13, HPB-ALL, and Amsalem T-cell lines. Following absorption with Amsalem cells, HD-MAR antiserum failed to react with Amsalem cells, yet reacted strongly with thymus cells and HD-MAR cells. The sensitivity of the various cell lines to the cytotoxic activity of HD-MAR antiserum absorbed with Amsalem cells showed a striking correlation with their capacity to form E-rosettes. Trypsin treatment of Amsalem cells eliminated their sensitivity to the cytotoxic effect of HD-MAR antisera. In contrast, trypsin-treated thymus and HD-MAR cells maintained their sensitivity to HD-MAR antiserum. Absorption of HD-MAR antiserum with trypsinized thymus cells did not affect the activity of the antiserum on untreated thymus, HD-MAR, and Amsalem cells, but eliminated its activity on trypsinized cells. Thus, all T-cell types tested seem to share a trypsin sensitive antigen. Amsalem cells, however, lack a trypsin resistant antigen present in other T-cell lines. A third antigenic determinant detected by HD-MAR antiserum seemed to be associated with the E-receptor. Preliminary observations indicate that HD-MAR antiserum is strongly cytotoxic for activated T-lymphocytes. The relationship of the antigenic specificities detected by the antiserum and the antigenic changes occurring in the membrane of activated T cells is under investigation.
UR - http://www.scopus.com/inward/record.url?scp=0020263185&partnerID=8YFLogxK
U2 - 10.1016/0198-8859(82)90037-4
DO - 10.1016/0198-8859(82)90037-4
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 6181032
AN - SCOPUS:0020263185
SN - 0198-8859
VL - 4
SP - 219
EP - 228
JO - Human Immunology
JF - Human Immunology
IS - 3
ER -